↓ Skip to main content

Ageing and Dementia Current and Future Concepts

Overview of attention for book
Cover of 'Ageing and Dementia Current and Future Concepts'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Vascular-ischemic dementia: an update
  3. Altmetric Badge
    Chapter 2 Frequency of white matter lesions and silent lacunar infarcts
  4. Altmetric Badge
    Chapter 3 CT and MRI rating of white matter changes
  5. Altmetric Badge
    Chapter 4 Risk factors and progression of small vessel disease-related cerebral abnormalities
  6. Altmetric Badge
    Chapter 5 Microangiopathy-related cerebral damage and angiotensinogen gene: from epidemiology to biology
  7. Altmetric Badge
    Chapter 6 Can small-vessel disease-related cerebral abnormalities be used as a surrogate marker for vascular dementia trials?
  8. Altmetric Badge
    Chapter 7 Reactive oxygen: its sources and significance in Alzheimer disease
  9. Altmetric Badge
    Chapter 8 Dysregulation of neuronal differentiation and cell cycle control in Alzheimer’s disease
  10. Altmetric Badge
    Chapter 9 A broader horizon of Alzheimer pathogenesis: ALZAS — an early serum biomarker?
  11. Altmetric Badge
    Chapter 10 Is mild cognitive impairment bridging the gap between normal aging and Alzheimer’s disease?
  12. Altmetric Badge
    Chapter 11 Vienna Transdanube Aging “VITA”: study design, recruitment strategies and level of participation
  13. Altmetric Badge
    Chapter 12 Conversion from preclinical to clinical stage of Alzheimer’s disease as shown by decline of cognitive function in carriers of the Swedish APP-mutation
  14. Altmetric Badge
    Chapter 13 The role of biological markers in the early and differential diagnosis of Alzheimer’s disease
  15. Altmetric Badge
    Chapter 14 Measuring cognition in advanced Alzheimer’s disease for clinical trials
  16. Altmetric Badge
    Chapter 15 Current drugs and future hopes in the treatment of Alzheimer’s disease
  17. Altmetric Badge
    Chapter 16 Development of human antibody fragments directed towards synaptic acetylcholinesterase using a semi-synthetic phage display library
  18. Altmetric Badge
    Chapter 17 Long-term stabilizing effect of cholinesterase inhibitors in the therapy of Alzheimer’ disease
  19. Altmetric Badge
    Chapter 18 Impact of muscarinic agonists for successful therapy of Alzheimer’s disease
  20. Altmetric Badge
    Chapter 19 Nicotinic receptor modulation: Advantages for successful Alzheimer’s disease therapy
  21. Altmetric Badge
    Chapter 20 Glutamate receptors as a target for Alzheimer’s disease — are clinical results supporting the hope?
  22. Altmetric Badge
    Chapter 21 Can estrogen play a significant role in the prevention of Alzheimer’s disease?
  23. Altmetric Badge
    Chapter 22 Neurotrophic factors and Alzheimer’s disease: are we focusing on the wrong molecule?
  24. Altmetric Badge
    Chapter 23 Nerve growth factor and cholinergic CNS neurons studied in organotypic brain slices
  25. Altmetric Badge
    Chapter 24 Sustained improvement of cognition and global function in patients with moderately severe Alzheimer’s disease:a double-blind, placebo-controlled study with the neurotrophic agent Cerebrolysin®
  26. Altmetric Badge
    Chapter 25 Improved global function and activities of daily living in patients with AD: a placebo-controlled clinical study with the neurotrophic agent Cerebrolysin®
  27. Altmetric Badge
    Chapter 26 Genomics and dementia — new drug targets ahead?
  28. Altmetric Badge
    Chapter 27 Are β-sheet breaker peptides dissolving the therapeutic problem of Alzheimer’s disease?
  29. Altmetric Badge
    Chapter 28 Glycoxidative stress creates a vicious cycle of neurodegeneration in Alzheimer's disease--a target for neuroprotective treatment strategies?
  30. Altmetric Badge
    Chapter 29 Pharmacological targets to inhibit alzheimer neurofibrillary degeneration
  31. Altmetric Badge
    Chapter 30 Generation and brain delivery of anti-aggregating antibodies against β-amyloid plaques using phage display technology
  32. Altmetric Badge
    Chapter 31 Effects of Cerebrolysin™ on amyloid-β deposition in a transgenic model of Alzheimer’s disease
  33. Altmetric Badge
    Chapter 32 Vitamin E binding protein A famin Protects Neuronal Cells in vitro
  34. Altmetric Badge
    Chapter 33 Recent developments in the pathology of Parkinson’s disease
Attention for Chapter 1: Vascular-ischemic dementia: an update
Altmetric Badge

Mentioned by

twitter
2 X users

Readers on

mendeley
21 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Vascular-ischemic dementia: an update
Chapter number 1
Book title
Ageing and Dementia Current and Future Concepts
Published in
Journal of neural transmission Supplementum, January 2002
DOI 10.1007/978-3-7091-6139-5_1
Pubmed ID
Book ISBNs
978-3-21-183796-2, 978-3-70-916139-5
Authors

K. A. Jellinger, Jellinger, K. A.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 21 100%

Demographic breakdown

Readers by professional status Count As %
Professor 5 24%
Student > Bachelor 4 19%
Student > Ph. D. Student 2 10%
Professor > Associate Professor 2 10%
Student > Master 2 10%
Other 3 14%
Unknown 3 14%
Readers by discipline Count As %
Medicine and Dentistry 8 38%
Neuroscience 3 14%
Psychology 3 14%
Agricultural and Biological Sciences 2 10%
Linguistics 1 5%
Other 0 0%
Unknown 4 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 February 2023.
All research outputs
#16,643,630
of 24,486,486 outputs
Outputs from Journal of neural transmission Supplementum
#79
of 101 outputs
Outputs of similar age
#108,290
of 128,013 outputs
Outputs of similar age from Journal of neural transmission Supplementum
#4
of 4 outputs
Altmetric has tracked 24,486,486 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 101 research outputs from this source. They receive a mean Attention Score of 4.1. This one is in the 13th percentile – i.e., 13% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 128,013 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 3rd percentile – i.e., 3% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one.